title: Bcl-2 antagonists and cancer: from the clinic, back to the bench.
authors.affiliation: Faculty of Life Sciences, University of Manchester, Manchester, UK. mauro.esposti@manchester.ac.uk
authors.forename: M Degli
authors.initials: MD
authors.lastname: Esposti
mesh_terms: D000818:Animals; D051023:BH3 Interacting Domain Death Agonist Protein / Q000378:metabolism; D001713:Biphenyl Compounds / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D009369:Neoplasms / Q000378:metabolism*; D009596:Nitrophenols / Q000737:chemistry / Q000494:pharmacology; D010879:Piperazines / Q000737:chemistry / Q000494:pharmacology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D013449:Sulfonamides / Q000737:chemistry / Q000494:pharmacology; D057170:Translational Research, Biomedical
chemical_list: C501332:ABT-737; D051023:BH3 Interacting Domain Death Agonist Protein; D001713:Biphenyl Compounds; D009596:Nitrophenols; D010879:Piperazines; D019253:Proto-Oncogene Proteins c-bcl-2; D013449:Sulfonamides